Display options
Share it on

Curr HIV/AIDS Rep. 2015 Mar;12(1):117-26. doi: 10.1007/s11904-014-0251-7.

HIV testing updates and challenges: when regulatory caution and public health imperatives collide.

Current HIV/AIDS reports

Bernard M Branson

Affiliations

  1. Scientific Affairs LLC, Eldorado Drive NE, Atlanta, GA, 30345, USA, [email protected].

PMID: 25656347 DOI: 10.1007/s11904-014-0251-7

Abstract

Numerous improvements in HIV testing technology led recently to the first revision of recommendations for diagnostic laboratory testing in the USA in 25 years. Developments in HIV testing continue to produce tests that identify HIV infection earlier with faster turnaround times for test results. These play an important role in identifying HIV infection during the highly infectious acute phase, which has implication for both patient management and public health interventions to control the spread of HIV. Access to these developments, however, is often delayed by the regulatory apparatus for approval and oversight of HIV testing in the USA. This article summarizes recent developments in HIV diagnostic testing technology, outlines their implications for clinical management and public health, describes current systems of regulatory oversight for HIV testing in the USA, and proposes alternatives that could expedite access to improved tests as they become available.

References

  1. J Clin Microbiol. 2009 Aug;47(8):2639-42 - PubMed
  2. PLoS One. 2014 Mar 06;9(3):e86461 - PubMed
  3. J Clin Virol. 2011 Dec;52 Suppl 1:S63-6 - PubMed
  4. Antimicrob Agents Chemother. 1993 May;37(5):1037-42 - PubMed
  5. J Clin Virol. 2011 Dec;52 Suppl 1:S23-7 - PubMed
  6. J Clin Virol. 2013 Dec;58 Suppl 1:e123-6 - PubMed
  7. Transfusion. 2003 Oct;43(10):1428-32 - PubMed
  8. J Mol Diagn. 2005 Feb;7(1):2-7 - PubMed
  9. PLoS One. 2013 Dec 12;8(12):e80629 - PubMed
  10. Arch Intern Med. 2010 Jan 11;170(1):66-74 - PubMed
  11. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):121-4 - PubMed
  12. J Clin Virol. 2011 Dec;52 Suppl 1:S35-40 - PubMed
  13. MMWR Morb Mortal Wkly Rep. 2011 Jul 29;60(29):985-8 - PubMed
  14. Am J Med. 1997 May 19;102(5B):117-24; discussion 125-6 - PubMed
  15. J Clin Virol. 2011 Dec;52 Suppl 1:S71-6 - PubMed
  16. AIDS. 2006 Aug 1;20(12):1655-60 - PubMed
  17. PLoS Med. 2012;9(7):e1001232 - PubMed
  18. J Clin Microbiol. 2008 May;46(5):1588-95 - PubMed
  19. J Med Microbiol. 2008 Oct;57(Pt 10):1228-33 - PubMed
  20. AIDS. 2013 Jul 17;27(11):1687-95 - PubMed
  21. J Clin Virol. 2011 Dec;52 Suppl 1:S17-22 - PubMed
  22. J Infect Dis. 2012 Dec 15;206(12):1946-7; author reply 1949-50 - PubMed
  23. J Infect Dis. 2006 Sep 15;194(6):725-33 - PubMed
  24. Antimicrob Agents Chemother. 2009 Sep;53(9):3611-9 - PubMed
  25. J Clin Virol. 2013 Dec;58 Suppl 1:e85-91 - PubMed
  26. J Infect Dis. 2010 Oct 15;202 Suppl 2:S270-7 - PubMed
  27. J Clin Virol. 2010 May;48(1):40-3 - PubMed
  28. AIDS. 2007 Aug 20;21(13):1723-30 - PubMed
  29. J Infect Dis. 2010 Apr 15;201 Suppl 1:S7-15 - PubMed
  30. J Clin Virol. 2013 Dec;58 Suppl 1:e104-7 - PubMed
  31. Commun Dis Rep CDR Rev. 1992 Oct 9;2(11):R128-30 - PubMed
  32. J Virol Methods. 2007 Jul;143(1):86-94 - PubMed
  33. J Clin Virol. 2014 Dec;61(4):623-4 - PubMed
  34. Implement Sci. 2011 Jun 10;6:62 - PubMed
  35. MMWR Morb Mortal Wkly Rep. 2013 Jun 21;62(24):489-94 - PubMed
  36. J Infect Dis. 2007 Apr 1;195(7):951-9 - PubMed
  37. J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S187-99 - PubMed
  38. Curr Opin HIV AIDS. 2010 Jul;5(4):283-90 - PubMed
  39. J Clin Microbiol. 2003 May;41(5):2153-5 - PubMed
  40. AIDS Clin Care. 2003 Mar;15(3):19-23, 30 - PubMed
  41. J Clin Virol. 2011 Dec;52 Suppl 1:S41-4 - PubMed
  42. Clin Infect Dis. 2009 Aug 1;49(3):444-53 - PubMed
  43. JAMA. 1998 Nov 18;280(19):1699-701 - PubMed
  44. J Infect Dis. 2008 Sep 1;198(5):687-93 - PubMed
  45. PLoS Pathog. 2013 Mar;9(3):e1003211 - PubMed
  46. JAMA Intern Med. 2013 Mar 25;173(6):475-6 - PubMed
  47. Clin Infect Dis. 2010 Dec 1;51(11):1334-42 - PubMed
  48. J Clin Virol. 2014 Aug;60(4):399-401 - PubMed
  49. J Infect Dis. 2010 Apr 15;201 Suppl 1:S52-8 - PubMed
  50. J Clin Virol. 2013 Dec;58 Suppl 1:e119-22 - PubMed
  51. J Clin Virol. 2013 Dec;58 Suppl 1:e97-e103 - PubMed
  52. MMWR Morb Mortal Wkly Rep. 2002 Nov 22;51(46):1051-2 - PubMed
  53. N Engl J Med. 2011 May 19;364(20):1943-54 - PubMed
  54. AIDS. 2006 Aug 1;20(12):1597-604 - PubMed
  55. MMWR Recomm Rep. 2005 Nov 11;54(RR-13):1-25; quiz CE1-4 - PubMed
  56. J Clin Virol. 2013 Dec;58 Suppl 1:e108-12 - PubMed
  57. MMWR Suppl. 1989 Jul 21;38(7):1-7 - PubMed
  58. J Clin Virol. 2011 Dec;52 Suppl 1:S67-9 - PubMed
  59. J Clin Microbiol. 2014 Sep;52(9):3377-83 - PubMed
  60. Transfusion. 1997 Mar;37(3):352-4 - PubMed
  61. J Infect Dis. 2004 May 15;189(10):1785-92 - PubMed
  62. J Clin Virol. 2013 Dec;58 Suppl 1:e92-6 - PubMed
  63. J Infect Dis. 2012 Jan 1;205(1):87-96 - PubMed
  64. AIDS. 2003 Sep 5;17(13):1871-9 - PubMed
  65. MMWR Morb Mortal Wkly Rep. 2009 Nov 27;58(46):1296-9 - PubMed
  66. MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4 - PubMed
  67. J Clin Virol. 2013 Dec;58 Suppl 1:e54-8 - PubMed
  68. MMWR Morb Mortal Wkly Rep. 2008 Jun 20;57(24):660-5 - PubMed
  69. J Clin Virol. 2013 Dec;58 Suppl 1:e113-8 - PubMed
  70. J Clin Microbiol. 2014 Jan;52(1):103-7 - PubMed

MeSH terms

Publication Types